Breaking News Instant updates and real-time market news.

GES

Guess

$22.85

-0.325 (-1.40%)

, SMTC

Semtech

$49.85

-0.15 (-0.30%)

19:00
08/29/18
08/29
19:00
08/29/18
19:00

Fly Intel: After Hours Movers

UP AFTER EARNINGS: Guess (GES) up 9.6%... Semtech (SMTC) up 8.0%... Tilly's (TLYS) up 10.7%. ALSO HIGHER: Verastem (VSTM) up 1.5% after naming new CFO. DOWN AFTER EARNINGS: Net 1 UEPS Technologies (UEPS) down 11.7%... At Home Group (HOME) down 4.2%... Salesforce (CRM) down 3.6%... PVH Corp (PVH) down 1.8%.

GES

Guess

$22.85

-0.325 (-1.40%)

SMTC

Semtech

$49.85

-0.15 (-0.30%)

TLYS

Tilly's

$18.03

0.24 (1.35%)

VSTM

Verastem

$9.65

0.21 (2.22%)

UEPS

Net 1 UEPS

$8.75

-0.16 (-1.80%)

HOME

At Home Group

$37.28

0.275 (0.74%)

CRM

Salesforce

$154.80

1.825 (1.19%)

PVH

PVH Corp.

$156.79

0.68 (0.44%)

  • 29

    Aug

  • 29

    Aug

  • 29

    Aug

  • 29

    Aug

  • 29

    Aug

  • 30

    Aug

  • 30

    Aug

  • 04

    Sep

  • 04

    Sep

  • 04

    Sep

  • 05

    Sep

  • 06

    Sep

  • 06

    Sep

  • 07

    Sep

  • 13

    Sep

  • 19

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 01

    Oct

  • 02

    Oct

  • 05

    Oct

  • 15

    Nov

GES Guess
$22.85

-0.325 (-1.40%)

02/26/18
RILY
02/26/18
UPGRADE
Target $20
RILY
Buy
Guess upgraded to Buy from Neutral at B. Riley FBR
B. Riley FBR analyst Susan Anderson upgraded Guess to Buy with an unchanged price target of $20. The analyst views the valuation as attractive at current share levels and believes retro T-shirts and a denim comeback will drive improved business fundamentals.
12/22/17
RILY
12/22/17
INITIATION
Target $17
RILY
Neutral
Guess resumed with a Neutral at B. Riley FBR
B. Riley FBR analyst Susan Anderson resumed coverage of Guess with a Neutral rating and $17 price target.
02/26/18
BWSF
02/26/18
NO CHANGE
Target $56
BWSF
Buy
Inter Parfums licensing deal with Guess affirms bull case, says BWS Financial
BWS Financial analyst Hamed Khorsand said Inter Parfums' (IPAR) licensing deal with Guess (GES) came as somewhat of a surprise, noting that the latter has been using Coty (COTY) for fragrances since 2010. This deal affirms his bull case that Inter Parfums management is not complacent and is looking for growth opportunities, said Khorsand, who added that he believes the company is still looking for more transactions like its acquisition of Rochas. He keeps a Buy rating and $56 price target on Inter Parfums.
SMTC Semtech
$49.85

-0.15 (-0.30%)

07/20/18
STFL
07/20/18
INITIATION
Target $60
STFL
Buy
Semtech initiated with a Buy at Stifel
Stifel analyst Tore Svanberg initiated Semtech with a Buy rating and $60 price target, citing his view of its key technology leadership in end markets including IoT, data centers and mobile handsets.
07/20/18
07/20/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. OneMain Holdings (OMF) reinstated with an Equal Weight at Barclays. 2. Viking Therapeutics (VKTX) initiated with a Buy at SunTrust. 3. Semtech (SMTC) initiated with a Buy at Stifel. 4. Axon (AAXN) initiated with a Buy at Needham. 5. Sonoma Pharmaceuticals (SNOA) assumed with a Speculative Buy at Benchmark. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/27/18
PIPR
08/27/18
NO CHANGE
Target $57
PIPR
Overweight
Semtech price target raised to $57 from $50 at Piper Jaffray
Piper Jaffray analyst Harsh Kumar raised his price target for Semtech to $57 saying he's confident the company can meet July quarter estimates, with the possibility of "modest upside" given the strength in most of its major end markets. The analyst believes Semtech is one of the best organic growth stories in the semiconductor landscape and reiterates an Overweight rating on the shares.
08/27/18
RBCM
08/27/18
NO CHANGE
Target $55
RBCM
Outperform
Semtech price target raised to $55 from $50 at RBC Capital
RBC Captial analyst Mitch Steves raised his price target on Semtech to $55 and kept his Outperform rating ahead of its Q2 results. The analyst notes that the company management's recently highlighted focus on higher operating margins at the Analyst Day sets up a potential earnings beat while its revenue tracks in line. Steves adds that if Semtech's LoRa technology continues its growth trajectory of about 100%, investors should become "more confident" in the company's earnings outlook.
TLYS Tilly's
$18.03

0.24 (1.35%)

08/13/18
PIVT
08/13/18
INITIATION
Target $19
PIVT
Buy
Tilly's initiated with a Buy at Pivotal Research
Pivotal Research analyst Mitch Kummetz started Tilly's with a Buy rating and $19 price target. The company should be able to comp well and grow its earnings over the balance of the year, especially as it laps easy digital comparisons, Kummetz tells investors in a research note. He believes Tilly's catalysts are "mostly positive."
VSTM Verastem
$9.65

0.21 (2.22%)

08/09/18
RAJA
08/09/18
NO CHANGE
RAJA
Verastem price target raised to $12 from $7 at Raymond James
06/15/18
CANT
06/15/18
NO CHANGE
Target $17
CANT
Overweight
Verastem capital raise removes overhang, says Cantor Fitzgerald
Cantor Fitzgerald analyst Mara Goldstein believes Verastem's 7.1M share placement to a single institution removes an overhang on the shares. The raise bumps the company's cash to at least $140M, which will go a long way in removing an overhang on the shares ahead of the FDA action date of October 5, Goldstein tells investors in a research note. She continues to believe that the market for duvelisib is larger than Verastem's valuation suggests. Goldstein keeps an Overweight rating on the shares with a $17 price target.
07/09/18
OPCO
07/09/18
NO CHANGE
Target $16
OPCO
Outperform
Verastem price target raised to $16 from $11 at Oppenheimer
Oppenheimer analyst Leah Rush Cann raised her price target for Verastem to $16 from $11 to account for an increased average forward price-to-sales multiple of the biotechnology sector. The analyst reiterates an Outperform rating on the shares.
07/13/18
BTIG
07/13/18
INITIATION
Target $17
BTIG
Buy
Verastem initiated with a Buy at BTIG
BTIG analyst Robert Hazlett initiated Verastem with a Buy rating and a price target of $17. The analyst cites the potential of the company's pipeline - namely the "late-stage, first-in-class molecule Duvelisib that selectively targets the delta and gamma phosphoinositide 3-kinase isoforms, central signaling pathways in cancer cell proliferation and survival". Hazlett adds that its " successful Phase 3 DUO trial in relapsed/refractory chronic lymphocytic leukemia, combined with solid data from the Phase 2 DYNAMO study in refractory follicular lymphoma, have led to Duvelisib receiving a Priority Review from FDA" with an upcoming Oct 5th PDUFA, as well as a licensing deal. The analyst models potential U.S. peak revenue over $500M and international revenue over $350M in Duvelisib's initial indications.
UEPS Net 1 UEPS
$8.75

-0.16 (-1.80%)

07/31/18
MAXM
07/31/18
INITIATION
Target $24
MAXM
Buy
Net 1 UEPS initiated with a Buy at Maxim
As reported earlier, Maxim analyst Allen Klee initiated Net 1 UEPS with a Buy rating and a price target of $24. The analyst says the company's earnings should trough in Q4, adding that the market is underestimating its ability to recapture revenue in South Africa market while also pushing for growth in other regions. Klee believes that the company's international expansion in South Korea, China, India and Europe should produce long-term growth while also noting its conservative balance sheet and free cash flow generation.
07/31/18
07/31/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Pampa Energia (PAM) initiated with an Overweight at JPMorgan. 2. Net 1 UEPS (UEPS) initiated with a Buy at Maxim. 3. eXp World Holdings (EXPI) initiated with an Overweight at Stephens. 4. Capital Southwest (csWC) initiated with an Outperform at JMP Securities. 5. WMIH (WMIH) initiated with an Outperform at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/30/18
MAXM
07/30/18
INITIATION
Target $24
MAXM
Buy
Net 1 UEPS initiated with a Buy at Maxim
Maxim initiated Net 1 UEPS with a Buy and $24 price target.
06/28/18
SIDC
06/28/18
INITIATION
Target $18
SIDC
Buy
Net 1 UEPS initiated with a Buy at Sidoti
Sidoti initiated Net 1 UEPS with a Buy and $18 price target.
HOME At Home Group
$37.28

0.275 (0.74%)

08/21/18
JEFF
08/21/18
NO CHANGE
Target $45
JEFF
Buy
At Home Group's reinventions in 2h19 'progressing well,' says Jefferies
Jefferies analyst Jonathan Matuszewski assumed coverage of At Home Group with a Buy rating and $45 price target, telling investors in a research note that his analysis of interest in patio product corroborates recent results, and near-peak levels of search for accent rugs suggests reinventions in 2H19 are progressing well.
07/12/18
WBLR
07/12/18
NO CHANGE
WBLR
Outperform
At Home Group pullback on tariffs a buying opportunity, says William Blair
William Blair analyst Daniel Hofkin recommends using the current pullback in shares of At Home Group as an opportunity to add to positions. The impact the impact of tariffs on imported products from China is likely to be "considerably smaller" than some may fear, Hofkin tells investors in a research note. Among various categories, the tariffs would affect furniture and furnishings made from a range of materials, including bamboo, rattan, wood, and reinforced plastics, for example, the analyst points out. He believes, however, that At Home Group "should be considerably better positioned than average to withstand the tariffs." Further, Hofkin thinks the company's business "remains solidly on track, with trends nicely improved relative to the weather-affected first quarter." He keeps an Outperform rating on the shares.
06/26/18
06/26/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Micron (MU) upgraded to Neutral from Sell at UBS with analyst Timothy Arcuri saying he sees major producers taking a more anticipatory approach to DRAM supply, which will help Micron avert the downside case he previously laid out. 2. CenturyLink (CTL) upgraded to Buy from Hold at Jefferies with analyst Scott Goldman citing relatively low consumer exposure, favorable operating trends, a sustainable dividend, and improving leverage. 3. At Home Group (HOME) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Simeon Gutman stating that its new stores are ramping quicker than initially anticipated and he has increased confidence in the company's ability to generate high teens sales growth. 4. Lam Research (LRCX) upgraded to Buy from Neutral at UBS with analyst Timothy Arcuri saying NAND shipments are already down roughly 50% and he now thinks the September bar is set so low that a favorable trend can develop into 2019. 5. MercadoLibre (MELI) upgraded to Overweight from Sector Weight at KeyBanc with analyst Brad Erickson stating that he is more bullish on the company's prospects in payments after visiting several companies in the FinTech/payments and e-commerce space in Latin America. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/26/18
06/26/18
UPGRADE
Target $47

Overweight
Morgan Stanley admits to being 'wrong' on At Home Group, upgrades to Overweight
As previously reported, Morgan Stanley analyst Simeon Gutman upgraded At Home Group to Overweight from Equal Weight, stating that its new stores are ramping quicker than initially anticipated and he has increased confidence in the company's ability to generate high teens sales growth, and low- to mid-single comparable store sales growth. "We've been wrong and while we have missed an initial leg of this story's outperformance, we believe it still has a long way to go," Gutman tells investors in his note. He raised his price target on At Home Group shares to $47 from $35.
CRM Salesforce
$154.80

1.825 (1.19%)

08/21/18
COWN
08/21/18
NO CHANGE
Target $165
COWN
Outperform
Salesforce price target raised to $165 from $155 at Cowen
Cowen analyst J. Derrick Wood raised his price target on Salesforce to $165 from $155 ahead of Q2 results. The analyst said channel checks indicate a solid beat and raise set-up, citing a re-acceleration in Sales and Service Cloud, growing Einstein adoption, and lower competition. Wood reiterated his Outperform rating on Salesforce shares.
08/22/18
WEDB
08/22/18
NO CHANGE
Target $160
WEDB
Outperform
Salesforce price target raised to $160 from $150 at Wedbush
Wedbush analyst Steve Koenig raised his price target for Salesforce to $160 from $150 as his checks point to a strong demand environment and sustained momentum for Salesforce. While the analyst does not have evidence to suggest a repeat of the Q1 large deal performance, his checks anecdotally point to large deals closed in major verticals, and more in the pipeline. Koenig expects Salesforce's Q2 numbers will be strong, although the run-up in the shares year to date and over the last 90 days may create a more difficult setup. The analyst reiterates an Outperform rating on the shares.
08/22/18
RBCM
08/22/18
NO CHANGE
Target $155
RBCM
Outperform
Salesforce price target raised to $155 from $146 at RBC Capital
RBC Capital analyst Ross MacMillan raised his price target on Salesforce to $155 and kept his Outperform rating, saying his checks suggest continued "strong demand, success in multi-cloud deals at enterprise customers and pricing power". The analyst notes that the set-up on the stock is also "attractive" considering the implied organic constant-currency billings growth of around 15%. MacMillan adds that Salesforce has a historical pattern of beating Q2 consensus by about 5%, though this year's results may be skewed by the adoption of ASC606 standard.
08/22/18
JEFF
08/22/18
NO CHANGE
Target $168
JEFF
Buy
Salesforce price target raised to $168 from $155 at Jefferies
Jefferies analyst John DiFucci raised his price target for Salesforce to $168 ahead of the company's Q2 results. The analyst expects Salesforce meet or exceed consensus Q2 billings growth of 22%. Enterprise checks reflect strong results, particularly in Europe and across verticals, and a "healthy" second half of 2018 pipeline, DiFucci tells investors in a pre-earnings research note. The analyst keeps a Buy rating on the shares.
PVH PVH Corp.
$156.79

0.68 (0.44%)

06/26/18
FBCO
06/26/18
NO CHANGE
Target $185
FBCO
Outperform
PVH Corp. price target raised to $185 from $178 at Credit Suisse
Credit Suisse analyst Michael Binetti raised his price target for PVH Corp. to $185 from $178 as he has increased conviction that it can easily beat plan in 2018. Guide implies a significant revenue slowdown, but the analyst sees no reason why trends would slow amid ongoing global momentum, new growth sources, and visible share donors. He reiterates an Outperform rating on the shares.
06/25/18
06/25/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Twilio (TWLO) initiated with an Overweight at Piper Jaffray. 2. Albemarle (ALB) initiated with a Buy at BofA/Merrill. 3. PVH Corp. (PVH) initiated with a Sell at Goldman Sachs. 4. New Relic (NEWR) initiated with a Buy at Deutsche Bank. 5. Alibaba (BABA) initiated with a Buy at Argus. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/20/18
DBAB
08/20/18
NO CHANGE
Target $175
DBAB
Buy
Deutsche Bank says 'sticking with' off-price, athletic brands in apparel space
Deutsche Bank analyst Paul Trussell previewed earnings for apparel companies, telling investors in a research note that he is "sticking with" off-price, the brands and athletic brands over specialty retailers and department stores. Trussell expects beats from Burlington Stores (BURL), Ross Stores (ROST), TJX (TJX), PVH (PVH), Foot Locker (FL) and Lululemon (LULU), along with American Eagle Outfitters (AEO) and Buckle (BKE) as the outliers in the specialty group and Kohl's (KSS), and says he is "a bit more cautious" for the frest of his apparel coverage given stretched valuations. Trussell raised his price target for Burlington Stores to $175 from $167, to $96 from $91 for Ross and to $105 from $100 fro TJX, but cut his price target to $171 from $176 for PVH.
06/25/18
GSCO
06/25/18
INITIATION
GSCO
Sell
PVH Corp. initiated with a Sell at Goldman Sachs
Goldman Sachs analyst Alexandra Walvis initiated PVH Corp (PVH) with a Sell, telling investors in a research note that while the company has benefited from a strong acceleration in growth in Tommy Hilfiger and Calvin Klein, she believes momentum is peaking as a number of tailwinds fade. This morning, Walvis also initiated shares of Tapestry (TPR) with a Conviction Buy and Tiffany (TIF) and VFC (VFC) with a Buy.

TODAY'S FREE FLY STORIES

TEVA

Teva

$18.46

-0.56 (-2.94%)

18:34
12/14/18
12/14
18:34
12/14/18
18:34
Hot Stocks
Teva, Celltrion announce FDA approval of HERZUMA »

Celltrion and Teva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVG

Pretium Resources

$7.43

(0.00%)

18:11
12/14/18
12/14
18:11
12/14/18
18:11
Hot Stocks
Pretium Resources: Brucejack approved for production hike to 3,800 tonnes/day »

Pretium Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$15.47

-0.2 (-1.28%)

17:52
12/14/18
12/14
17:52
12/14/18
17:52
Periodicals
FCA says four U.S. plants to have down-time in January, Detroit News says »

Fiat Chrysler said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNOA

Sonoma Pharmaceuticals

$0.75

-0.0342 (-4.36%)

, CCNI

Command Center

$4.00

-0.075 (-1.84%)

17:43
12/14/18
12/14
17:43
12/14/18
17:43
Hot Stocks
Sonoma Pharmaceuticals CEO Jim Schutz resigns, Frederick Sandford succeeds »

Sonoma Pharmaceuticals…

SNOA

Sonoma Pharmaceuticals

$0.75

-0.0342 (-4.36%)

CCNI

Command Center

$4.00

-0.075 (-1.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$62.09

-1.47 (-2.31%)

, XLU

Utilities SPDR

$56.81

-0.13 (-0.23%)

17:38
12/14/18
12/14
17:38
12/14/18
17:38
General news
Week ending ETF scorecard: Energy, Financials lead the decline »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$62.09

-1.47 (-2.31%)

XLU

Utilities SPDR

$56.81

-0.13 (-0.23%)

IYR

DJ US Real Estate Index Fund

$80.37

-0.14 (-0.17%)

XLP

Consumer Staples Sector SPDR

$54.51

-0.97 (-1.75%)

XLY

Consumer Discretionary Sector SPDR

$102.33

-1.75 (-1.68%)

XLB

S&P Select Materials SPDR

$51.37

-0.37 (-0.72%)

XLF

Financial Select Sector

$24.25

-0.24 (-0.98%)

XLV

Health Care Select Sector SPDR

$88.99

-3.05 (-3.31%)

XLK

Technology Select Sector SPDR

$64.58

-1.6 (-2.42%)

XLI

Industrial Select Sector SPDR

$67.06

-0.95 (-1.40%)

GLD

SPDR Gold Shares

$117.10

-0.44 (-0.37%)

SLV

iShares Silver Trust

$13.69

-0.175 (-1.26%)

USO

United States Oil Fund

$10.83

-0.38 (-3.39%)

UNG

United States Natural Gas Fund

$30.78

-2.64 (-7.90%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$83.17

-0.365 (-0.44%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$112.72

-0.125 (-0.11%)

TLT

iShares 20+ Year Treasury Bond Fund

$118.47

0.38 (0.32%)

IEF

iShares 7-10 Year Treasury Bond ETF

$102.57

0.19 (0.19%)

SHY

iShares 1-3 Year Treasury Bond

$83.31

0.055 (0.07%)

IWD

iShares Russell 1000 Value

$116.15

-1.71 (-1.45%)

IWF

iShares Russell 1000 Growth

$135.70

-2.96 (-2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEI

Ecology & Environment

$11.50

0.2 (1.77%)

17:35
12/14/18
12/14
17:35
12/14/18
17:35
Hot Stocks
Ecology & Environment receives Nasdaq noncompliance notice »

On December 13, 2018,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBC

Luther Burbank

$8.96

-0.045 (-0.50%)

17:34
12/14/18
12/14
17:34
12/14/18
17:34
Hot Stocks
Luther Burbank announces systematic share repurchase plan »

Luther Burbank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYND

MYnd Analytics

$1.33

0.01 (0.76%)

17:31
12/14/18
12/14
17:31
12/14/18
17:31
Syndicate
Breaking Syndicate news story on MYnd Analytics »

MYnd Analytics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLGT

Radiant Logistics

$4.76

-0.06 (-1.24%)

17:29
12/14/18
12/14
17:29
12/14/18
17:29
Syndicate
Breaking Syndicate news story on Radiant Logistics »

Radiant Logistics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KALV

KalVista

$22.62

-1.39 (-5.79%)

17:29
12/14/18
12/14
17:29
12/14/18
17:29
Syndicate
Breaking Syndicate news story on KalVista »

KalVista files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$260.61

-4.8 (-1.81%)

17:25
12/14/18
12/14
17:25
12/14/18
17:25
Hot Stocks
POTUS names Mick Mulvaney acting WH chief of staff »

U.S. President Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$260.61

-4.8 (-1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$169.87

-2.585 (-1.50%)

17:20
12/14/18
12/14
17:20
12/14/18
17:20
Hot Stocks
Raytheon awarded $149.44M Navy contract for Standard Missile-2 Block IIIC »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$100.08

-2.73 (-2.66%)

17:15
12/14/18
12/14
17:15
12/14/18
17:15
Syndicate
Breaking Syndicate news story on EOG Resources »

EOG Resources files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNCB

First National Community Bancorp, Inc.

$9.35

0.04 (0.43%)

17:14
12/14/18
12/14
17:14
12/14/18
17:14
Hot Stocks
First National Community Bancorp names R. Gregory Collins as new EVP »

FNCB Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXT

Textron

$49.49

-0.48 (-0.96%)

17:14
12/14/18
12/14
17:14
12/14/18
17:14
Hot Stocks
Textron awarded $314.29M Navy contract modification for LLTM procurement »

Textron has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLDM

Fluidigm

$7.79

-0.39 (-4.77%)

17:14
12/14/18
12/14
17:14
12/14/18
17:14
Hot Stocks
Breaking Hot Stocks news story on Fluidigm »

Levin Capital lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

WTFC

Wintrust Financial

$67.41

-0.88 (-1.29%)

17:06
12/14/18
12/14
17:06
12/14/18
17:06
Hot Stocks
Wintrust Financial acquires Elektra Holding in roughly $51.9M deal »

Wintrust Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMC

AMC Entertainment

$14.51

-0.35 (-2.36%)

17:04
12/14/18
12/14
17:04
12/14/18
17:04
Syndicate
Breaking Syndicate news story on AMC Entertainment »

AMC Entertainment files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFX

Equifax

$97.19

0.07 (0.07%)

17:03
12/14/18
12/14
17:03
12/14/18
17:03
Hot Stocks
Equifax Canada acquires JLR Inc. »

Equifax Canada announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

DFS

Discover

$61.83

-1.41 (-2.23%)

17:03
12/14/18
12/14
17:03
12/14/18
17:03
Hot Stocks
Discover executive chairman Nelms to step down effective December 31 »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUTO

AutoWeb

$2.34

-0.01 (-0.43%)

17:00
12/14/18
12/14
17:00
12/14/18
17:00
Hot Stocks
Daniel M. Negari reports 7.1% stake in AutoWeb »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNI

Canadian National

$77.33

-1.39 (-1.77%)

16:46
12/14/18
12/14
16:46
12/14/18
16:46
Hot Stocks
Canadian National, Unifor Local 100 reach tentative agreement »

CN announced that a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$45.80

-1.66 (-3.50%)

16:44
12/14/18
12/14
16:44
12/14/18
16:44
Recommendations
Cisco analyst commentary at Tigress Financial »

Tigress Financial sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 10

    Jan

  • 04

    Mar

TEL

TE Connectivity

$73.01

-0.59 (-0.80%)

16:44
12/14/18
12/14
16:44
12/14/18
16:44
Hot Stocks
TE Connectivity raises quarterly dividend to 46c from 44c per share »

TE Connectivity board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEL

TE Connectivity

$73.01

-0.59 (-0.80%)

16:42
12/14/18
12/14
16:42
12/14/18
16:42
Hot Stocks
TE Connectivity board approves $1.5B share repurchase authorization »

TE Connectivity announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.